Stocktoria
Palomino Laboratories Inc. PALX
OTC · stock · Semiconductors & Related Devices · website · IPO 2026-04-16
Palomino Laboratories Inc. financials (annual, from 10-K)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating income | -$2.7M | -$6,123 | -$83,937 |
| Net income | -$3.2M | -$16,198 | -$83,937 |
| EPS (diluted) | $-0.47 | $-0.01 | $-0.02 |
| Operating cash flow | -$1.3M | -$4,870 | -$79,379 |
| Cash & equivalents | $8.1M | $134,657 | $380 |
| Total assets | $8.4M | $138,125 | $380 |
| Total liabilities | $336,458 | $156,431 | $111,621 |
| Shareholders' equity | $8.1M | -$18,306 | -$18,306 |
Source: SEC EDGAR filings · CIK 0001938569 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.